Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00765557|
Recruitment Status : Available
First Posted : October 3, 2008
Last Update Posted : October 3, 2008
We hypothesize fecal retention is the primary source of bladder dysfunction in some children with Urge Syndrome. Our specific aims are:
- To test this hypothesis through a prospective, randomized, double-blinded and placebo-controlled trial of laxatives for children diagnosed with US.
- To determine if a validated questionnaire of bowel activity administered to the family, and when appropriate, the patient, will identify those likely to benefit from laxative therapy for bladder dysfunction.
- To determine if the abdominal X-Ray of the kidneys, ureters and bladder (KUB) assessment of fecal loading corresponds to answers on the questionnaire regarding incidence of constipation, and/or response to laxative therapy for US.
|Condition or disease||Intervention/treatment|
|Urge Syndrome||Drug: Miralax|
|Study Type :||Expanded Access|
|Official Title:||Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge Syndrome|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00765557
|Contact: Warren T Snodgrass, M.D.||214-456-2483||Warren.Snodgrass@childrens.com|